These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 24200514)

  • 1. Acute exercise preferentially redeploys NK-cells with a highly-differentiated phenotype and augments cytotoxicity against lymphoma and multiple myeloma target cells.
    Bigley AB; Rezvani K; Chew C; Sekine T; Pistillo M; Crucian B; Bollard CM; Simpson RJ
    Brain Behav Immun; 2014 Jul; 39():160-71. PubMed ID: 24200514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute exercise preferentially redeploys NK-cells with a highly-differentiated phenotype and augments cytotoxicity against lymphoma and multiple myeloma target cells. Part II: impact of latent cytomegalovirus infection and catecholamine sensitivity.
    Bigley AB; Rezvani K; Pistillo M; Reed J; Agha N; Kunz H; O'Connor DP; Sekine T; Bollard CM; Simpson RJ
    Brain Behav Immun; 2015 Oct; 49():59-65. PubMed ID: 25578514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latent cytomegalovirus infection enhances anti-tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humans.
    Bigley AB; Rezvani K; Shah N; Sekine T; Balneger N; Pistillo M; Agha N; Kunz H; O'Connor DP; Bollard CM; Simpson RJ
    Clin Exp Immunol; 2016 Aug; 185(2):239-51. PubMed ID: 26940026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous serum collected 1 h post-exercise enhances natural killer cell cytotoxicity.
    Gupta P; Bigley AB; Markofski M; Laughlin M; LaVoy EC
    Brain Behav Immun; 2018 Jul; 71():81-92. PubMed ID: 29656052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NKG2A Expression Is Not
    Mahaweni NM; Ehlers FAI; Sarkar S; Janssen JWH; Tilanus MGJ; Bos GMJ; Wieten L
    Front Immunol; 2018; 9():1415. PubMed ID: 29988376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal selection of natural killer cells to kill myeloma: the role of HLA-E and NKG2A.
    Sarkar S; van Gelder M; Noort W; Xu Y; Rouschop KM; Groen R; Schouten HC; Tilanus MG; Germeraad WT; Martens AC; Bos GM; Wieten L
    Cancer Immunol Immunother; 2015 Aug; 64(8):951-63. PubMed ID: 25920521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen Receptors.
    Oei VYS; Siernicka M; Graczyk-Jarzynka A; Hoel HJ; Yang W; Palacios D; Almåsbak H; Bajor M; Clement D; Brandt L; Önfelt B; Goodridge J; Winiarska M; Zagozdzon R; Olweus J; Kyte JA; Malmberg KJ
    Cancer Immunol Res; 2018 Apr; 6(4):467-480. PubMed ID: 29459477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daratumumab augments alloreactive natural killer cell cytotoxicity towards CD38+ multiple myeloma cell lines in a biochemical context mimicking tumour microenvironment conditions.
    Mahaweni NM; Bos GMJ; Mitsiades CS; Tilanus MGJ; Wieten L
    Cancer Immunol Immunother; 2018 Jun; 67(6):861-872. PubMed ID: 29500635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Adaptive NK Cells and CD8 T Cells by HLA-C Correlates with Allogeneic Hematopoietic Cell Transplantation and with Cytomegalovirus Reactivation.
    Horowitz A; Guethlein LA; Nemat-Gorgani N; Norman PJ; Cooley S; Miller JS; Parham P
    J Immunol; 2015 Nov; 195(9):4524-36. PubMed ID: 26416275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuning Natural Killer Cell Anti-multiple Myeloma Reactivity by Targeting Inhibitory Signaling
    Mahaweni NM; Ehlers FAI; Bos GMJ; Wieten L
    Front Immunol; 2018; 9():2848. PubMed ID: 30564241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia induced impairment of NK cell cytotoxicity against multiple myeloma can be overcome by IL-2 activation of the NK cells.
    Sarkar S; Germeraad WT; Rouschop KM; Steeghs EM; van Gelder M; Bos GM; Wieten L
    PLoS One; 2013; 8(5):e64835. PubMed ID: 23724099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expansion of NKG2A-LIR1- natural killer cells in HLA-matched, killer cell immunoglobulin-like receptors/HLA-ligand mismatched patients following hematopoietic cell transplantation.
    Rathmann S; Glatzel S; Schönberg K; Uhrberg M; Follo M; Schulz-Huotari C; Kaymer M; Veelken H; Finke J; Fisch P
    Biol Blood Marrow Transplant; 2010 Apr; 16(4):469-81. PubMed ID: 20044012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced Expression of Siglec-7, NKG2A, and CD57 on Terminally Differentiated CD56
    Zulu MZ; Naidoo KK; Mncube Z; Jaggernath M; Goulder PJR; Ndung'u T; Altfeld M; Thobakgale CF
    AIDS Res Hum Retroviruses; 2017 Dec; 33(12):1205-1213. PubMed ID: 28810810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
    Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A
    Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of NK cell clones obtained using interleukin-2 and gene-modified K562 cells revealed the ability of "senescent" NK cells to lose CD57 expression and start expressing NKG2A.
    Streltsova MA; Erokhina SA; Kanevskiy LM; Lee DA; Telford WG; Sapozhnikov AM; Kovalenko EI
    PLoS One; 2018; 13(12):e0208469. PubMed ID: 30517188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microchip-Based Single-Cell Imaging Reveals That CD56dimCD57-KIR-NKG2A+ NK Cells Have More Dynamic Migration Associated with Increased Target Cell Conjugation and Probability of Killing Compared to CD56dimCD57-KIR-NKG2A- NK Cells.
    Forslund E; Sohlberg E; Enqvist M; Olofsson PE; Malmberg KJ; Önfelt B
    J Immunol; 2015 Oct; 195(7):3374-81. PubMed ID: 26320254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NKG2C+ NK Cells for Immunotherapy of Glioblastoma Multiforme.
    Murad S; Michen S; Becker A; Füssel M; Schackert G; Tonn T; Momburg F; Temme A
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD56
    Kobyzeva PA; Streltsova MA; Erokhina SA; Kanevskiy LM; Telford WG; Sapozhnikov AM; Kovalenko EI
    J Leukoc Biol; 2020 Oct; 108(4):1379-1395. PubMed ID: 32930385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cell lines preferentially kill clonogenic multiple myeloma cells and decrease myeloma engraftment in a bioluminescent xenograft mouse model.
    Swift BE; Williams BA; Kosaka Y; Wang XH; Medin JA; Viswanathan S; Martinez-Lopez J; Keating A
    Haematologica; 2012 Jul; 97(7):1020-8. PubMed ID: 22271890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-lymphoma cells escape rituximab-triggered elimination by NK cells through increased HLA class I expression.
    Borgerding A; Hasenkamp J; Engelke M; Burkhart N; Trümper L; Wienands J; Glass B
    Exp Hematol; 2010 Mar; 38(3):213-21. PubMed ID: 20056126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.